SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Coya Therapeutics, Inc. is a clinical-stage biotechnology company which engages in developing proprietary medicinal products to modulate the function of regulatory T cells. The company was founded by Howard Berman in 2020 and is headquartered in Houston, TX.

Coya Therapeutics Inc

Fueled by promising trial results and a strategic partnership with Dr. Reddy's, Coya is trending as the community focuses on its potential to disrupt the neurodegenerative disease space. Discussions revolve around the upcoming Alzheimer's data and the ALS trial, with many speculating about a potential acquisition. The company's novel approach and strong financial position are also driving bullish sentiment.

Targa Resources Corp. engages in the business of gathering, compressing, treating, processing, transporting, and purchasing and selling natural gas. It operates through the following segments: Gathering and Processing, and Logistics and Transportation, and Other. The Gathering and Processing segment includes assets used in the gathering, and purchase and sale of natural gas produced from oil and gas wells. The Logistics and Transportation segment refers to the activities and assets necessary to convert mixed natural gas liquids (NGLs) into NGL products. The Other contains the results of commodity derivative activity mark-to-market gains and losses related to derivative contracts. The company was founded on October 27, 2005 and is headquartered in Houston, TX.

Targa Resources Corp

Targa Resources is trending due to its upcoming inclusion in the S&P 500, replacing Nielsen Holdings. The community is discussing the implications of this move and the company's overall strength in the energy sector. Bullish sentiment is fueled by analyst ratings and potential benefits from increased natural gas demand and strategic positioning in the Permian Basin.

Dynex Capital, Inc. is an internally managed mortgage real estate investment trust. It engages in the business of investing in mortgage-backed securities. The company was founded on December 18, 1987 and is headquartered in Glen Allen, VA.

Dynex Capital, Inc.

Dynex Capital is trending as investors discuss its attractive monthly dividend and potential entry points, with some weighing it against similar REITs. Community members are highlighting the company's consistent dividend payments and solid management team. Broader market volatility and interest rate trends appear to be influencing discussions around DX.

Direxion Shares ETF Trust - Direxion Daily Homebuilders & Supplies Bull 3X Shares

Direxion Daily Homebuilders & Supplies Bull 3X Shares

The Direxion Daily Homebuilders & Supplies Bull 3X Shares ($NAIL) is trending as traders discuss potential entry points based on technical indicators like falling wedge patterns and RSI levels, while some express hesitancy to invest. Community members are also weighing the ETF's outlook against broader market factors, including interest rate cut expectations and housing market data. Bullish sentiment anticipates momentum to continue into the spring, while bearish viewpoints cite concerns about a potential dip into the $30s over the winter.

Sagimet Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics for the treatment of infectious diseases. Its lead drug candidate, denifanstat, is an oral, once-daily pill and selective fatty acid synthase (FASN) inhibitor in development for the treatment of nonalcoholic steatohepatitis (NASH). The company was founded by Urs F. Greber, Ari Helenius, and Lucas Pelkmans on December 19, 2006 and is headquartered in San Mateo, CA.

Sagimet Biosciences Inc - Ordinary Shares - Series A

Sagimet Biosciences Inc

Sagimet Biosciences is trending due to positive Phase 3 acne trial results, sparking community excitement about its potential in the Chinese market and a new mechanism of action. Community members are actively discussing the undervaluation of the stock, potential buyout scenarios, and upcoming catalysts including the KOL event next week. Some are concerned about the absence of news on the mash program and the need for a funding partner.

Snowflake, Inc. engages in the provision of cloud data warehousing software. The firm offers Data Cloud, an ecosystem where Snowflake customers, partners, data providers, and data consumers can break down data silos and derive value from data. Its platform supports a range of use cases including data warehousing, data lakes, data engineering, data science, data application development, and data sharing. The cloud-native architecture consists of layers across storage, compute, and cloud services. The storage layer ingests structured and semi-structured data to create a unified data record. The compute layer provides dedicated resources to enable users to access common data sets for many use cases without latency. The cloud services layer optimizes each use case's performance requirements with no administration. The company was founded by Marcin Zukowski, Thierry Cruanes, and Benoit Dageville on July 23, 2012 and is headquartered in Bozeman, MT.

Snowflake Inc

Snowflake is trending as investors assess its potential in the AI-driven data cloud sector, particularly after recent partnerships and analyst upgrades. Community discussions revolve around its long-term growth prospects and ability to maintain its competitive edge against major players. Bullish sentiment seems to be building around the stock's technical setup and potential for further upside.

Dropbox, Inc. engages in providing file backup, sync, and sharing solutions. Its products include Dropbox, Dropbox Dash beta, Dropbox Backup, Dropbox Replay, Dropbox Sign, Dropbox Capture, DocSend, and Dropbox Early Access. It operates through the United States and International geographical segments. The company was founded by Andrew W. Houston and Arash Ferdowsi in May 2007 and is headquartered in San Francisco, CA.

Dropbox Inc - Ordinary Shares - Class A

Dropbox Inc

Dropbox is trending as investors discuss its steady growth in cloud collaboration and secure storage, while others speculate about a potential acquisition given the company's history of share buybacks. Community members are also weighing the company's advancements in AI-driven product features against concerns about competition and demand for its core services. Option activity suggests traders are positioning themselves for a potential price swing.

The Compound Governance Token is a governance token on the Compound Finance lending protocol, COMP allows the owner to delegate voting rights to the address of their choice; the owner’s wallet, another user, an application, or a DeFi expert. Anybody can participate in Compound governance by receiving delegation, without needing to own COMP.  Anybody with 1% of COMP delegated to their address can propose a governance action; these are simple or complex sets of actions, such as adding support for a new asset, changing an asset’s collateral factor, changing a market’s interest rate model, or changing any other parameter or variable of the protocol that the current administrator can modify.

Compound

Compound (COMP) is trending amid fluctuating community sentiment, with some traders betting on a pump while others express frustration over recent price action and dilution concerns. Discussions include potential DeFi integrations, comparisons to AAVE, and speculation about the Compound Foundation's financial health. Community members are closely watching BTC and ETH movements for potential market cues.

The Mosaic Co. engages in the production and marketing of concentrated phosphate and potash crop nutrients. It operates through the following segments: Phosphates, Potash, and Mosaic Fertilizantes. The Phosphates segment is involved in the ownership and operation of mines and production facilities which produce concentrated phosphate crop nutrients and phosphate-based animal feed ingredients, and processing plants which produce concentrated phosphate crop nutrients. The Potash segment includes mining, processing, and selling potash. The Mosaic Fertilizantes segment focuses on mines, chemical plants, crop nutrient blending and bagging facilities, port terminals, and warehouses. The company was founded on March 25, 2004 and is headquartered in Tampa, FL.

Mosaic Company

MOS is trending due to a recent announcement regarding production interruptions in potash and phosphate, impacting sales volume guidance and spurring community discussion around its effect on the stock. Despite the negative news, some investors view the dip as a buying opportunity, citing the company's strong underlying fundamentals, value, and dividend. Community members also mentioned the potential for long-term gains and a possible rotation into the agriculture sector.

GE Vernova, Inc. is a electric power industry. Its products and services generate, transfer, orchestrate, convert, and store electricity. The firm operates through the following segments: Power, Wind and Electrification. The Power segment includes design, manufacture, and servicing of gas, nuclear, hydro, and steam technologies, providing a critical foundation of dispatchable, flexible, stable, and reliable power. The Wind segment includes wind generation technologies, inclusive of onshore and offshore wind turbines and blades. The Electrification segment includes grid solutions, power conversion, electrification software, and solar and storage solutions technologies required for the transmission, distribution, conversion, storage, and orchestration of electricity from point of generation to point of consumption. The Company was founded November 09, 2021 and is headquartered in Cambridge, Massachusetts.

GE Vernova Inc.

GE Vernova is trending as investors discuss its potential role in powering AI data centers and the broader clean energy transition. Community members are analyzing recent price movements, technical indicators, and analyst ratings, with some highlighting the stock's strong backlog and growth prospects, while others point to valuation concerns and potential overvaluation. Discussions also include GE Vernova's potential partnerships and its positioning within the energy sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Allogene's Q1 Earnings In Line With Estimates, Sales Nil

Elevation Oncology downgraded as it halts lead asset on disappointing trials

Investing.com -- Wall Street cut rating on  Elevation Oncology  Inc (NASDAQ:ELEV) after the company announced it will discontinue development of its lead asset, EO-3021, due to disappointing efficacy in a Phase 1 trial. Analysts now see limited near-term catalysts, with Elevation pivoting to its HER3-targeted ADC, EO-1022, which is still in preclinical development.

Elevation Oncology to Participate in Upcoming Investor Conferences

Elevation Oncology to Participate in Upcoming Investor Conferences Elevation Oncology to Participate in Upcoming Investor Conferences PR Newswire BOSTON, Feb. 25, 2025 BOSTON, Feb. 25, 2025...

Cutting-Edge Cancer Therapies Lead the Way into a Transformative Year

Cutting-Edge Cancer Therapies Lead the Way into a Transformative Year Cutting-Edge Cancer Therapies Lead the Way into a Transformative Year PR Newswire VANCOUVER, BC, Jan. 15, 2025 Issued on behalf...

Elevation Oncology Provides Updates on Differentiated ADC Programs and Upcoming Milestones

Elevation Oncology Provides Updates on Differentiated ADC Programs and Upcoming Milestones Elevation Oncology Provides Updates on Differentiated ADC Programs and Upcoming Milestones PR Newswire...

Elevation Oncology Expands Pipeline with Nomination of EO-1022, a HER3 ADC for the Treatment of HER3-expressing Solid Tumors

Elevation Oncology Expands Pipeline with Nomination of EO-1022, a HER3 ADC for the Treatment of HER3-expressing Solid Tumors Elevation Oncology Expands Pipeline with Nomination of EO-1022, a HER3 ADC...

Elevation Oncology Presents Preclinical Proof-of-Concept Data Supporting Combination Potential of EO-3021 with VEGFR2 or PD-1 Inhibitors at ESMO Immuno-Oncology Annual Congress 2024

Elevation Oncology Presents Preclinical Proof-of-Concept Data Supporting Combination Potential of EO-3021 with VEGFR2 or PD-1 Inhibitors at ESMO Immuno-Oncology Annual Congress 2024 Elevation...

Elevation Oncology to Present at the Piper Sandler 36th Annual Healthcare Conference

Elevation Oncology to Present at the Piper Sandler 36th Annual Healthcare Conference Elevation Oncology to Present at the Piper Sandler 36th Annual Healthcare Conference PR Newswire BOSTON, Nov. 26...

Elevation Oncology Receives Fast Track Designation from the FDA for EO-3021 for the Treatment of Adult Patients with Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer Expressing Claudin 18.2

Elevation Oncology Receives Fast Track Designation from the FDA for EO-3021 for the Treatment of Adult Patients with Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer Expressing...

Elevation Oncology to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Elevation Oncology to Present at the H.C. Wainwright 26th Annual Global Investment Conference Elevation Oncology to Present at the H.C. Wainwright 26th Annual Global Investment Conference PR Newswire...

Elevation Oncology, Inc. is a precision oncology company, which engages in the development of targeted therapeutics for the treatment of cancer in genomically-defined patient populations. The firm’s program is focused on patients with advanced solid tumors harboring an NRG1 fusion. The company was founded by Shawn M. Leland in 2019 and is headquartered in Boston, MA.

Elevation Oncology Inc

$AMZN

$MSFT

$GOOGL

$ORCL

Which cloud infrastructure stock offers the best long-term opportunity right now?

ELEV
Elevation Oncology Inc

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest ELEV News

ELEVElevation Oncology Inc